Characterization of subviral components resulting from treatment of rabies virus with tri(n-butyl) phosphate.
D000596:Amino Acids / Q000378:metabolism; D001963:Bromelains / Q000494:pharmacology; D002247:Carbon Isotopes; D002460:Cell Line; D002499:Centrifugation, Density Gradient; D002501:Centrifugation, Zonal; D002794:Choline / Q000378:metabolism; D004171:Diploidy; D004589:Electrophoresis, Disc; D005944:Glucosamine / Q000378:metabolism; D006023:Glycoproteins / Q000302:isolation & purification; D006801:Humans; D008055:Lipids / Q000302:isolation & purification; D008168:Lung; D008970:Molecular Weight; D010756:Phosphoric Acids / Q000494:pharmacology*; D012367:RNA, Viral / Q000302:isolation & purification*; D011820:Rabies virus / Q000032:analysis / Q000187:drug effects*; D013229:Stearic Acids / Q000378:metabolism; D014316:Tritium; D014529:Uridine / Q000378:metabolism; D014764:Viral Proteins / Q000302:isolation & purification*; D014779:Virus Replication
D000596:Amino Acids; D002247:Carbon Isotopes; D006023:Glycoproteins; D008055:Lipids; D010756:Phosphoric Acids; D012367:RNA, Viral; D013229:Stearic Acids; D014764:Viral Proteins; D014316:Tritium; D001963:Bromelains; D005944:Glucosamine; D002794:Choline; D014529:Uridine